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Objective: This study aimed to formulate the epigallocatechin gallate (EGCG) from green tea into ethosomes and measure the resulting increases in 
skin penetration using a rat model.
Methods: Ethosomes were formulated using ethanol concentrations of 25% (F1), 30% (F2), and 35% (F3), and those with favorable characteristics 
were then incorporated into a cream for the determination of penetration into Franz diffusion cells.
Results: We showed that the formulation F3 had the best spherical morphology, a Z-average value of 73.01 nm, a polydispersity index of 0.26, a 
zeta potential of −47.77±3.93 mV, and the highest percentage of drug entrapment (49.46%±0.62%) compared with the other formulas. The total 
cumulative EGCG penetration from the resulting ethosomal cream was 905.75±49.47 μg/cm2, whereas that from the cream containing green tea leaf 
extract was only 413.92±52.83 μg/cm2.
Conclusion: These data indicate a higher penetration of EGCG from ethosomal green tea cream than from cream containing non-ethosomal green tea 
extract.
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INTRODUCTION
Since natural materials are considered safer and have fewer side effects 
than synthetic materials, pharmaceutical preparations containing 
natural active substances are increasingly desired [1]. Green tea leaves 
(Camellia sinensis L. Kuntze) are a common source of natural ingredients 
with health benefits for general and oral health [2,3]. Green tea leaves are 
credited to have antiproliferative activity and antibacterial activity [4]. 
Green tea leaves contain multiple polyphenols and derivative flavonoids 
known as catechins. Among these, epigallocatechin gallate (EGCG) is the 
most prevalent in green tea leaves [5] and has antioxidant activity that 
prevents cell damage from oxidative stress, particularly in the skin [6]. 
Accordingly, antioxidants from green tea may inhibit the development of 
cancer, heart disease, and immune suppression and could serve as anti-
inflammatory, antiaging, and anti-wrinkle agents [2,5,6].
Several studies have shown that EGCG has poor bioavailability and is 
subject to the first-pass metabolism in the liver and very low absorption 
through the small intestine [7]. Most digested EGCG does not enter the 
blood and remains in the colon, where it is degraded by microbiota [8]. 
Therefore, transdermal drug delivery of EGCG may offer an alternative 
that overcomes the problems associated with oral administration of EGCG.
Transdermal drug delivery systems have been designed to facilitate the 
passage of drug compounds through the skin and into the circulation [9]. 
Transdermal drug delivery avoids gastrointestinal disturbances, first-
line metabolism, and fluctuations in circulating drug levels that are 
associated with oral routes of delivery [10,11]. In addition, transdermal 
administration is non-invasive and convenient and leads to improved 
patient compliance [12,13]. However, effective delivery requires 
penetration of the drug through the skin and into the circulatory system. 
Since EGCG is hydrophilic (Log p=0.48) and has a large molecular mass 
(458.37 Da), its skin penetration is highly limited [14]. To address this, 
drug carrier systems such as lipid nanovesicles are widely considered.
Various lipid nanovesicles can be used as drug carrier systems to 
increase penetration of active ingredients through the skin [15]. For 
example, ethosomes can be used as phospholipid-based carrier systems 
and have high ethanol contents (20%–45%). Ethanol potently enhances 
skin penetration due to the interdigitation effects of ethanol on the 
lipid bilayers of skin tissues. Ethosomes were previously designed as 
modified lipid nanovesicles that contain phospholipids, ethanol, and 
water depending on the stability of the active ingredient. The particle 
sizes of ethosomes vary between 10 and 1000 nm [16], but ethosomes 
have higher entrapment capacities [10,13] and lead to higher 
transdermal flux than conventional liposomes [15,16]. In this study, 
we formulated EGCG from green tea into ethosomes and measured the 
resulting increases in skin penetration using a rat model.
In general, ethosomes are used as drug carriers in semisolid formulations 
such as gels and creams [17]. Creams are made as oil-in-water (o/w type) 
emulsions and are commonly used as preferred preparations. Since these 
o/w-type creams are slightly oily and can spread well, they have the 
advantages of convenience and ease of application to the skin [18].
In this study, ethosomes of green tea leaf extracts (C. sinensis L. Kuntze) 
were formulated into cream preparations and were then compared with 
cream containing green tea leaf extracts regarding in vitro penetration 
tests in Franz diffusion cells from the skin of female Sprague Dawley rats.
MATERIALS AND METHODS
Materials
Green tea leaf extract (C. sinensis L. Kuntze; Andy biotech, China), EGCG 
standard (Sigma-Aldrich, Singapore), Lipoid P 30 (kindly provided 
by Lipoid GMBH, Germany), stearic acid, cetyl alcohol, and isopropyl 
myristate (pharmaceutical grade), triethanolamine (Croda, Singapore), 
dimethicone and propylene glycol (Dow Chemical Pacific, Singapore), 
sodium sulfite anhydrous and butylated hydroxytoluene (BHT; Merck, 
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Germany), 1,1-diphenyl-2-picrylhydrazyl (DPPH; Sigma-Aldrich), 
ethanol 96% and methanol (Merck), ascorbic acid (Sigma-Aldrich), 
potassium dihydrogen phosphate, sodium hydroxide, glacial acetic acid, 
and acetonitrile (Merck), and Sprague Dawley rats (Bogor Agricultural 
Institute, Indonesia) were purchased from their respective suppliers.
Determination of EGCG contents in extracts using high-performance 
liquid chromatography (HPLC)
The EGCG contents were determined using HPLC with C18 (250×4.6 mm) 
columns and an optimized mobile phase of acetic acid solution (0.05%, 
v/v) and acetonitrile (87:13, v/v). At pH 3.5–4.0, 10 mg samples were 
dissolved in 100 mL aliquots of mobile phase with 5 min sonication, 
filtered through 0.45 μm microfilters, and diluted 2.5 times with mobile 
phase. Subsequently, 20 μL aliquots of the resulting solutions were 
injected into the HPLC instrument at a flow rate of 1.0 mL/min and 
were then detected at a wavelength of 280 nm using an ultraviolet (UV)-
visible detector. All samples were measured 3 times.
Antioxidant activity tests of green tea leaf extracts
A Vitamin C solution was generated by mixing 1.0 mL of a stock Vitamin 
C solution with 1.0 mL of 100.0 μg/mL DPPH and 2.0 mL of methanol. 
The extract test solutions were obtained by mixing 1.0 mL of green tea 
leaf extract solution (ES) with 1.0 mL of 100.0 μg/mL DPPH and 2.0 mL 
of methanol. The blank solution was produced by mixing 3.0 mL of 
methanol with 1.0 mL of 100.0 μg/mL DPPH. All mixtures were shaken for 
a few seconds and then incubated at room temperature for 30 min. The 
antioxidant activities were then determined by measuring absorption 
using a UV-visible spectrophotometry at DPPH wavelength maximum.
Preparation of ethosomes
Ethosomes were prepared using the mechanical dispersion method 
described by Maheshwari et al. [19] with slight modifications (Table 1). 
Briefly, lipoid P 30 was dissolved in 25 mL aliquots of dichloromethane 
and the resulting soluble phospholipids were then placed in dry round 
flasks. Dichloromethane was then evaporated at 37°C±2°C using a 
rotary evaporator equipped with a vacuum. On the formation of the thin 
layers of phospholipids on the bottoms of the flasks, a flow of N2 gas 
was applied and the samples were stored in the refrigerator for up to 
24 h. Thin layers of phospholipids were then hydrated in hydroethanol 
solutions containing phosphate buffer (pH 5.5), propylene glycol, 
ethanol, and green tea leaves at 37°C with rotation at 150 rpm. On the 
formation of the ethosomal suspensions, ultrasonication was performed 
for 2 min with an amplitude of 25, and the ethosomal suspensions were 
then cooled at room temperature and stored in a refrigerator. The 
characteristics of the ethosome formulations are listed in Table 1.
Characterization of ethosomes
Morphology
Ethosome morphology was examined using a transmission electron 
microscope after placing single drops of sample on a carbon-coated 
copper grid. The droplets were then dried at room temperature and 
stained using a phosphotungstic acid solution. The specimens were 
viewed under a microscope at a working voltage of 200 kV.
Determinations of particle size distributions, polydispersity indexes, 
and zeta potentials
Particle size distributions and zeta potentials were measured using 
dynamic light scattering methods with a computerized inspection 
system (Malvern Zetasizer). Z-average values and emerging 
polydispersity indexes were recorded, and zeta potentials were 
measured using fresh cuvettes.
Entrapment efficiency
The entrapment efficiency was determined using indirect methods in 
which the concentrations of EGCG were determined according to those 
remaining outside the vesicles. Briefly, 0.5 mL samples of ethosome 
suspensions (ET) were mixed with 1.0 mL aliquots of hydration solution 
and centrifuged at 14,000 rpm 4 times for 30 min each. The supernatants 
were then analyzed using HPLC with a detector wavelength of 280 nm. 
The entrapment efficiencies were then calculated by dividing (Qt–Qs) 
with Qt, then times 100%, where Qt is the total EGCG concentration in 
ethosome suspensions (µg/mL) and Qs is the EGCG concentration in the 
supernatants (µg/mL).
Cream preparation
The cream formulations were made as ethosomal creams (CET) and 
creams without ethosomes (CE; Table 2). Initially, oil phase ingredients 
including stearic acid, cetyl alcohol, isopropyl myristate, and dimethicone 
were completely melted in a water bath at 70°C and then mixed with BHT 
and stirred until homogeneous. Aqueous phases were then prepared 
by adding a solution containing sodium sulfite, propylene glycol, 
triethanolamine, and distilled water and then heating in a water bath at 
70°C. The oil and water phases were then mixed using a homogenizer 
with stirring at 950 rpm for 15 min. After cooling to 30°C, the green tea 
leaf and the ethosomal green tea extracts were added to the creams.
Evaluations of the creams
The ethosomal green tea extract and green tea extract creams were 
evaluated in terms of organoleptic properties, pH, homogeneity, 
viscosity, and rheology.
In vitro penetration tests
Skin penetration tests were conducted using Franz diffusion cells with 
membrane areas of 2.01 cm2 and a receptor compartment containing 
15 mL of phosphate buffer at pH 5.5. The liquid compartment was 
maintained at 37°C±0.5°C and was stirred with a magnetic stirrer at 
250 rpm. The skin specimens were placed between the donor and receptor 
compartments with the stratum corneum facing upward. Subsequently, 
1.0 g samples of the creams were applied to the skin surfaces, and up to 2.0 
mL samples were taken from the receptor compartment using a syringe 
after 10, 30, 60, 120, 240, 360, 480, 600, 720, 840, 960, 1080, 1200, 1320, 
and 1440 min. The EGCG concentrations were then determined in these 
samples using HPLC. In vitro penetration tests were performed 3 times.
Table 1: Ethosome formulations
Materials Concentrations (%)
F1 F2 F3
Green tea leaf 
extract
Equal to EGCG 
3.0
Equal to EGCG 
3.0
Equal to EGCG 
3.0
Lipoid P 30 6.0 6.0 6.0
Ethanol 25 30 35
Propylene glycol 10 10 10
Phosphate buffer 
pH 5.5
ad 100 ad 100 ad 100
EGCG: Epigallocatechin gallate
Table 2: Cream formulations
Materials Concentrations (% w/w)
CET CE
The sediment of ethosomal 
suspension green tea leaf 
extract
Equal to EGCG 1.0 -
Green tea leaf extract - Equal to EGCG 1.0
Stearic acid 10.0 10.0
Cetyl alcohol 2.3 2.3
Isopropyl myristate 3.05 3.05
Triethanolamine 2.0 2.0
Dimethicone 10.0 10.0
Propylene glycol 10.0 10.0
Anhydrous sodium sulfite 0.1 0.1
Butyl hydroxytoluene 0.1 0.1
Distilled water ad 100 ad 100
EGCG: Epigallocatechin gallate
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RESULTS AND DISCUSSION
Determinations of EGCG contents in extracts using HPLC
The EGCG contents in the green tea extracts were determined after 
optimizing and validating the HPLC analyses as described by Fangueiro 
et al. [20]. The analyses were performed using reverse-phase HPLC 
with a stationary phase C18 column and a mobile phase of 0.05% acetic 
acid: acetonitrile (87:13 v/v) at a flow rate of 1.0 mL/min. Since EGCG is 
easily degraded and unstable at high pH, the analyses were performed 
at pH 3.5–4. The EGCG contents in the green tea leaf extracts were 
53.50%±0.23%.
Antioxidant activity tests of green tea leaf extracts
The half inhibitory concentration (IC50) of the green tea leaf extract 
was 1.312 μg/mL and was much lower than that of the positive control 
ascorbic acid (IC50 2.735 μg/mL), indicating greater antioxidant activity 
of EGCG. These antioxidant properties of the green tea leaf extract 
indicate potential as a source of active ingredients in creams.
Formulation and characterization of ethosomes
Ethosomes were formulated using a mechanical dispersion method, 
and the best ethosome products were used as active ingredients in the 
cream formulation. The parameters of ethosome quality were spherical 
shape in analyses of particle morphology (Fig. 1), small size (73.01 nm), 
a polydispersity index of 0.26, a zeta potential of <−30 mV or >+30 mV, 
and the highest entrapment efficiency (49.46%±0.62%). Based on the 
data in Table 3, the best ethosome formulation was F3 and this was 
selected as an active ingredient for cream formulations, which were 
evaluated as described below.
Evaluation of cream dosage forms
Organoleptic tests showed that CET had a pale yellow color (PANTONE 
607 CP) and CE had a brownish-yellow color (PANTONE 461 CP) based 
on Pantone I Color Book [21]. The CET and CE creams were homogeneous 
when applied and had pH values of 5.40 and 5.45, respectively, indicating 
compatibility with the physiological pH of skin and the stability of EGCG. 
The viscosity values of the CET and CE creams were 11,800 and 11,200 cps, 
respectively, and both creams had thixotropic plastic rheology properties.
In vitro penetration tests
After applying the topical preparations, the cumulative 
amounts of EGCG that penetrated the Franz diffusion cells were 
2442.57±93.47 μg/cm2 for ES, 3897.67±1380.29 μg/cm2 for ethosome 
suspensions (ET), 413.92±52.83 μg/cm2 for CE, and 905.75±49.47 μg/cm2 
for CET (Fig. 2). We also calculated the flux of the active substance (EGCG) 
through rat skin and expressed these data as circulating EGCG per unit area 
per unit time. The flux values for ES, ETS, CE, and CET were 109.032±21.969, 
131.65±66.03, 12.66±1.45, and 40.96±5.56 μg.cm−2/h, respectively 
(Figs. 2-3). Based on these results, we suggest that CET achieves better 
penetration than CE. In addition, the ethosomal suspension had better 
penetration than the ES, indicating that ethosomes in topical creams 
can improve EGCG penetration through rat skin. The present ethosomal 
suspensions have a high ethanol content, which enhances penetration 
through hydrogen bond interactions with the phospholipid layers of the 
stratum corneum. Ethanol also facilitates the passage of the active ingredient 
into deeper skin layers by enhancing flexibility of following fusion of the 
ethosome vesicles with lipids in skin membranes [13,15,16].
CONCLUSION
Based on the data presented herein, we conclude that the F3 ethosome 
formula has the best characteristics of all formulas. The ethosomal 
cream with the F3 formula resulted in greater EGCG penetration 
through rat skin than the non-ethosomal cream.
Table 3: Physical characteristics of ethosomes
Sample Morphology Z-average (nm) Polydispersity index Zeta potential (mV) Entrapment efficiency (%)
F1 Spherical 220.5 0.34 −31.13±0.38 37.29±0.24
F2 Spherical 123.8 0.43 −24.33±1.12 42.75±1.00
F3 Spherical 73.01 0.26 −47.77±3.93 49.46±0.62
Fig. 2: Cumulative epigallocatechin gallate penetration from SE 
and ethosomal suspensions
Fig. 3: Cumulative epigallocatechin gallate penetration from CE 
and CET
Fig. 1: Morphology of ethosomal vesicles
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